Suchergebnisse - "Kugener, Luc"

PubPharm (136)

31

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

32

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

33

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone : true effect or mediated by a negative fluid balance achieved by RRT?

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Aug 24;24(1):518. - PMID 32831133

34

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

35

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

36

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status : fact or fiction?

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Aug 8;24(1):492. - PMID 32771054

37

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

38

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

39

Hepcidin is described as the master regulator of iron : could its removal by CRRT lead to iron dysmetabolism in the critically ill?

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4

CommentOn: Crit Care. 2019 Mar 9;23(1):81. - PMID 30850005

40

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?

enthalten in: Critical care | 2020

von Honore, P. | Barreto Gutierrez, L. | Kugener, L. | +4